The VERIGENE® System offers automated, cost-effective multiplex capabilities that rapidly and accurately detect infectious pathogens and drug resistance markers, without relying on time-consuming culture methods.

Delivery of this time-critical information enables clinicians to provide targeted patient care more quickly, potentially leading to improved patient outcomes, lower costs, optimized antibiotic therapy, reduced spread of antibiotic resistance, and most importantly, saved lives.

VERIGENE is powering faster treatment decisions in more than half of the top U.S. hospitals. VERIGENE’s ease of use makes it a valuable system for use in both hospital-based and reference laboratories.

Tests run on the VERIGENE platform are designed to target infections in the bloodstream, respiratory tract, and gastrointestinal tract.